Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-12-22 | 2023-01-26 | 179309 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-01-12 | 2023-06-09 | 180878 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-01-12 | 2023-01-19 | 180881 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180894 |
| TEVA-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180897 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2023-01-12 | 2023-10-05 | 180900 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-01-12 | 2023-02-16 | 180903 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180915 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-01-19 | 2023-02-09 | 181588 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181594 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181623 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183364 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183367 |
| TEVA-PHENIRAM | 4MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183371 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183377 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183380 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 |